PROBI AB |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 209 SEK | +1.95% |
|
+0.97% | +2.96% |
| Apr. 23 | Transcript : Probi AB, Q1 2024 Earnings Call, Apr 23, 2024 | |
| Apr. 23 | Probi AB Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
Presentation Operator MessageOperator (Operator)Welcome to Probi Q2 Report 2023. [Operator Ins...
This article is reserved for subscribers
Signed up already?
Log InNot subscribed yet?
Subscribe
Probi AB is a Sweden-based company engaged in the probiotics research and development. The Companyâs activities are divided into two business areas: Functional Foods, which focuses on the probiotics application in food in partnership with food companies; and Consumer Healthcares, which develops, commercializes and sells Probi probiotics in collaboration with a range of entities, such as pharmaceutical companies and firms related to the production of probiotics and self-care goods. Its brands portfolio comprises two trademarks: Probi Digestis and Probi Defendum. The Company's partners include Danone, Skanemejerier, NextFoods, Sanum Polska, Heinz, Kraft Foods, and Institut Rosell, among others. The Company is a parent of Probi Food AB and Probi Feed AB.
Sector
Pharmaceuticals
Calendar
2024-05-07
- Annual General Meeting
Trading Rating
Investor Rating
ESG Refinitiv
C+
EPS Revisions
| 1st Jan change | Capi. | |
|---|---|---|
| +2.96% | 217M | |
| +25.83% | 661B | |
| +27.00% | 566B | |
| -6.76% | 352B | |
| +20.34% | 332B | |
| +3.00% | 283B | |
| +13.09% | 231B | |
| +5.46% | 200B | |
| -9.61% | 195B | |
| -6.26% | 145B |
- Stock Market
- Equities
- PROB Stock
- News Probi AB
- Transcript : Probi AB, Q2 2023 Earnings Call, Jul 18, 2023
